George K. Ng, Chief Executive Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 10,000 shares at $2.70 ($27K) on 2024-01-30, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |